TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 5 | 2 | 1 | 5 | 27 | 44 | 12 | 15 |
| P | %wins | 80 | 80 | 60 | 100 | 100 | 60 | 80 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/15/15 16:30 | 1/13/15 | ARIA | Ariad Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Schlesinger Sarah J. | MA | D | P.m | 17 | 6.61 | 33 | 3 | 10 | 28 | I | -69 | -8 | 17 | 22 | -13 | -6 | -10 | -9 | 2 | 2 | 20 | 48 | 38 | -9 | |
12/18/14 16:09 | 12/16/14 | ARIA | Ariad Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Schlesinger Sarah J. | MA | D | P.m | 16 | 6.09 | 33 | 3 | 11 | 26 | I | -68 | 53 | -3 | 10 | 12 | -13 | -11 | 0 | 9 | 3 | -3 | 33 | 34 | -6 | |
11/13/14 16:27 | 11/11/14 | ARIA | Ariad Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Schlesinger Sarah J. | MA | D | P.m | 16 | 6.26 | 33 | 3 | 13 | 23 | I | -69 | 172 | 0 | 12 | 11 | 13 | 9 | 6 | -2 | -2 | 1 | 17 | 41 | 4 | |
10/16/14 16:27 | 10/14/14 | ARIA | Ariad Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Schlesinger Sarah J. | MA | D | P.m | 13 | 5.05 | 33 | 3 | 15 | 20 | I | -77 | 36 | -23 | 9 | -11 | 2 | 1 | 9 | 2 | 4 | 16 | 14 | 66 | 33 | |
9/11/14 16:38 | 8/12/14 | ARIA | Ariad Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Schlesinger Sarah J. | MA | D | P.m | 30 | 5.73 | 33 | 5 | 42 | 18 | I | -73 | -74 | -24 | -16 | -4 | -3 | -5 | -2 | 1 | 0 | -8 | 23 | 40 | 36 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |